We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$770M
AUM Growth
+$130M
Cap. Flow
+$122M
Cap. Flow %
15.79%
Top 10 Hldgs %
26%
Holding
984
New
94
Increased
180
Reduced
306
Closed
93

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$45.5M
2
MSFT icon
Microsoft
MSFT
+$17M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.08M
4
AMZN icon
Amazon
AMZN
+$7.25M
5
PLMR icon
Palomar
PLMR
+$7.01M

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Staples 7.79%
3 Financials 6.32%
4 Healthcare 4.92%
5 Consumer Discretionary 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
176
Sysco
SYY
$40.3B
$679K 0.09%
9,508
+9,500
+118,750% +$710K
SYF icon
177
Synchrony
SYF
$25.6B
$678K 0.09%
+14,357
New +$623K
ACGL icon
178
Arch Capital
ACGL
$33.6B
$677K 0.09%
6,713
-726
-10% -$70.6K
BDX icon
179
Becton Dickinson
BDX
$48.7B
$668K 0.09%
2,860
+2,850
+28,500% +$671K
GM icon
180
General Motors
GM
$76.8B
$666K 0.09%
14,335
+446
+3% +$20.1K
DB icon
181
Deutsche Bank
DB
$71.5B
$663K 0.09%
41,576
+12,328
+42% +$202K
MMM icon
182
3M
MMM
$94.3B
$659K 0.09%
+6,448
New +$629K
IJS icon
183
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
$657K 0.09%
6,756
IRM icon
184
Iron Mountain
IRM
$36.1B
$652K 0.08%
7,275
-1,251
-15% -$101K
COR icon
185
Cencora
COR
$61.2B
$651K 0.08%
2,888
-457
-14% -$106K
MCHP icon
186
Microchip Technology
MCHP
$46B
$650K 0.08%
7,100
-751
-10% -$68.7K
DGX icon
187
Quest Diagnostics
DGX
$26.3B
$647K 0.08%
4,728
-139
-3% -$19K
IVV icon
188
iShares Core S&P 500 ETF
IVV
$902B
$645K 0.08%
1,178
-71
-6% -$37.3K
MRK icon
189
Merck
MRK
$318B
$644K 0.08%
5,205
+735
+16% +$94.7K
VIST icon
190
Vista Energy
VIST
$7.32B
$643K 0.08%
14,145
-1,304
-8% -$57.7K
EMR icon
191
Emerson Electric
EMR
$88.3B
$639K 0.08%
+5,800
New +$641K
LEN.B icon
192
Lennar Class B
LEN.B
$20.8B
$632K 0.08%
4,771
-609
-11% -$83.6K
AXS icon
193
AXIS Capital
AXS
$7.55B
$617K 0.08%
8,730
+8,607
+6,998% +$584K
MITSY
194
DELISTED
MITSUI & CO LTD ADR (US)
MITSY
$616K 0.08%
670
-29
-4% -$26.7K
CRBG icon
195
Corebridge Financial
CRBG
$15B
$615K 0.08%
+21,126
New +$608K
NRG icon
196
NRG Energy
NRG
$24.8B
$607K 0.08%
7,791
+5,853
+302% +$453K
XCEM icon
197
Columbia EM Core ex-China ETF
XCEM
$2B
$600K 0.08%
18,782
-2,035
-10% -$63.1K
SNX icon
198
TD Synnex
SNX
$20.2B
$581K 0.08%
5,038
+2,269
+82% +$277K
CRH icon
199
CRH
CRH
$66.8B
$576K 0.07%
7,685
+250
+3% +$19.9K
RTX icon
200
RTX Corp
RTX
$301B
$576K 0.07%
5,735
+5,700
+16,286% +$589K

Similar funds

Atlas Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Atlas Capital Advisors held 984 positions worth $770M, up 20% from $640M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Atlas Capital Advisors deployed $122M of net new capital in Q2 2024, opening 94 new positions and adding to 180 existing holdings. Its largest new stake was Prudential Financial: 8,398 shares worth $984K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.6% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was iShares MSCI Intl Momentum Factor ETF, an estimated $3.1M trimmed.

  • Atlas Capital Advisors's largest Q2 2024 buy was Prudential Financial: 8,398 shares worth $984K.
  • Atlas Capital Advisors added most to Procter & Gamble in Q2 2024, an estimated $45.5M increase.
  • Atlas Capital Advisors's biggest Q2 2024 reduction was iShares MSCI Intl Momentum Factor ETF, cutting an estimated $3.1M.
  • Atlas Capital Advisors fully exited Affirm in Q2 2024, selling an estimated $510K.
  • Atlas Capital Advisors's ten largest holdings make up 26% of its $770M portfolio in Q2 2024.
  • Atlas Capital Advisors opened 94 new positions and closed 93 in Q2 2024.
  • Atlas Capital Advisors's portfolio value rose 20% quarter-over-quarter to $770M.

Based on Atlas Capital Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.